News

AddToAny

Google+ Facebook Twitter Twitter

Optical biopsy system for liver cancer

Researchers have developed an optical biopsy system that can distinguish between cancerous and healthy liver tissue.

The new technology could make it easier to diagnose liver cancer, which is the sixth most common cancer globally.

“The instrument is designed to be compatible with the needles currently used for liver biopsies,” said Evgenii Zherebtsov, a member of the research team.

“It could thus one day help surgeons more precisely navigate the biopsy instrument to decrease the number of errors in taking tissue samples that are used for diagnosis.”

The researchers report that the optical biopsy system can reliably distinguish between cancerous and healthy cells in mouse models.

The system also showed promise in preliminary tests conducted in people with suspected liver cancer.

The new optical biopsy system combines diffuse reflectance spectroscopy and lifetime fluorescence measurements to evaluate markers related to cellular metabolism, which differs between healthy and cancerous cells.

bit.ly/3tcwnRb

Related Articles

melanoma cell - CREDIT - science-photolibrary-f0403499

Phenotypic plasticity in melanoma: the impact on management strategies

Dr Ghada Elayat looks at the role of epithelial–mesenchymal transition in cancer and the implications for melanoma development.

A.I., Chat with AI, Artificial Intelligence-CREDIT-iStock-1494073860

AI search engines put to the test

Four proposed state-of-the-art image search engines for automating search and retrieval of digital histopathology slides were found to be of inadequate performance for routine clinical care, US research suggests.

alexandra grainey and team CREDIT_Supplied

My lab: innovative cellular pathology

A guided tour of cellular pathology at One Dorset Pathology.

big question headline

What safeguards and regulations would you like to see in place for AI pathology?

With artificial intelligence (AI) becoming ever more sophisticated and prevalent across society, combined with advances in digital pathology and the fast-paced progress in deep learning, we may be on the cusp of the era of AI in pathology. However, with technical, logistical and ethical barriers in place, we look at what measures are needed before widespread clinical adoption.

Top